ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial

Can Glycine + Amino Acids Be the Secret to Deep, Rejuvenating Sleep?

Lyme Disease Activists Take Fight to Washington D.C.

Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia bu...

New Envita Study Shows Chronic Lyme Disease "Fools" Immune System, Resistant to Antibiotics

Safely Burn Away Body Fat

Omega-3 fatty acids boost B vitamin brain benefit

Substantial health threat: Never-before-seen tick-borne disease

Lyme Advocates Call on IDSA to Focus on Patient Care Instead of Attacking Those in Distress

Restoring cellular energy signals may treat mitochondrial diseases in humans

 
Print Page
Email Article

Prozac May Offer Short-Term Fibromyalgia Relief

  [ 101 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 21, 2002



Mar 21, 1:12 PM ET

NEW YORK (Reuters Health) - Women with fibromyalgia experienced modest improvements in their condition after taking the antidepressant Prozac (fluoxetine) for 3 months, according to the results of a recent study.


Fibromyalgia is a chronic condition, often accompanied by depression and fatigue, in which a person feels pain in the muscles and tissues surrounding the joints. While the cause of fibromyalgia is unknown, researchers have found pain-processing abnormalities in the spines and brain stems of those with fibromyalgia.

About 2% of the US population is estimated to suffer from fibromyalgia, mostly women aged 50 years and older.

While previous studies of the effectiveness of antidepressants in patients with fibromyalgia have had mixed results, a report published in The American Journal of Medicine suggests that the dosages used in those studies may have been too low.

In the current study, Dr. Lesley M. Arnold of the University of Cincinnati Medical Center in Ohio and colleagues evaluated 51 non-depressed women with fibromyalgia. Twenty-five of the women took an average of 50 milligrams of Prozac per day for 3 months while the other 26 took an inactive placebo for the same time period.

At the beginning of the study, and in the 2nd, 4th, 6th, 8th and final week of the study, the patients completed questionnaires assessing their fibromyalgia symptoms and pain.

An improvement of 25% or more in overall symptoms was observed in 8 (32%) of the 25 women taking Prozac compared with only 4 (15%) of the women who took a placebo, the report indicates.

In addition, 56% of the Prozac takers had a 25% or better improvement in pain as measured by a standardized questionnaire compared with 15% of those who took the placebo, the investigators found.

A person is diagnosed with fibromyalgia if he or she has tenderness in at least 11 of 18 specific trigger points, including the hip, elbow, knee, the neck at the base of the skull and midway between the neck and shoulder. In the current analysis, no effect of antidepressants on pain at patients' trigger points was seen.

Arnold and colleagues point out that due to the study's short duration, the results may not be generalizable to longer time periods.

In an accompanying editorial, Dr. Patrick G. O'Malley writes that "most symptom-based studies define a greater than 50% improvement in symptoms as clinically significant. Thus, using only 25% improvement to define success may be overstating the efficacy of fluoxetine in fibromyalgia. Clearly, this is not a therapy that had a dramatic effect on outcomes in this sample."

The editorialist concludes that "it is safe to say that antidepressants, including SSRIs, are effective in treating patients who have such symptom syndromes as fibromyalgia, but many questions remain as to why, how much, which, and how long."

SSRIs, or selective serotonin reuptake inhibitors, are a class of antidepressant drugs--including Prozac--that increase levels of the brain chemical serotonin.

Eli Lilly, the pharmaceutical company that makes Prozac, funded the study.

SOURCE: The American Journal of Medicine 2002;112:191-197, 237-238.





Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Vitamins and Supplements

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

The Remarkable Benefits of Reishi Medicinal Mushrooms The Remarkable Benefits of Reishi Medicinal Mushrooms
Safely Burn Away Body Fat Safely Burn Away Body Fat
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea
When a Good Night's Sleep Is Just a Daydream... When a Good Night's Sleep Is Just a Daydream...

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS Diagnosis
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE  |  PRIVACY
CONTACT US
LIBRARY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing